NASDAQ · IENAX
Invesco Energy Fund
$48.16+$0.30 (+0.63%)
Invesco Energy Fund’s quoted price sits in the upper half of its reported 52-week range, 0.72% below the high.
Loading market information…
NYSE · THQ · USD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 02:47 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Abrdn Healthcare Opportunities Fund’s quoted price sits in the upper half of its reported 52-week range, 7.87% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Abrdn Healthcare Opportunities Fund’s forward annual dividend is $2.04 per share, paid monthly. The forward yield is 10.86% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Abrdn Healthcare Opportunities Fund’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Managed by Tekla Capital Management LLC, the Tekla Healthcare Opportunities Fund operates as a closed-end, balanced mutual fund. This fund strategically allocates capital across global public equity and debt markets, with a core investment objective of acquiring securities from companies within the healthcare sector. It also invests in various pooled investment vehicles. For its fixed income component, the fund holds corporate debt securities across the full spectrum of credit ratings. Established on April 2, 2014, and domiciled in the United States, its portfolio performance is measured against both the S&P 1500 Healthcare Index and the S&P 500 Index.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$48.16+$0.30 (+0.63%)
Invesco Energy Fund’s quoted price sits in the upper half of its reported 52-week range, 0.72% below the high.
$62.71+$0.48 (+0.77%)
RMB Mendon Financial Services Fund’s quoted price sits in the upper half of its reported 52-week range, 3.61% below the high.
$74.41-$1.20 (-1.59%)
Baron Fifth Avenue Growth Fund’s quoted price sits in the upper half of its reported 52-week range, 7.69% below the high.
$62.92-$0.72 (-1.13%)
Red Oak Technology Select Fund’s quoted price sits in the upper half of its reported 52-week range, 5.85% below the high.
$18.83-$0.03 (-0.16%)
Schwab Balanced Fund’s quoted price sits in the upper half of its reported 52-week range, 2.18% below the high.
$4.56-$0.03 (-0.65%)
Nuveen Credit Strategies Income Fund’s quoted price sits in the lower half of its reported 52-week range, 11.97% below the high.
$13.23-$0.07 (-0.49%)
DoubleLine Yield Opportunities Fund’s quoted price sits in the lower half of its reported 52-week range, 12.01% below the high.
$11.12+$0.05 (+0.41%)
CBRE Global Real Estate Income Fund’s quoted price sits in the lower half of its reported 52-week range, 26.49% below the high.
